Noul Supplies AI Diagnostic Platform miLab™ to Charité, Europe's Leading University Hospital
- Written by PR Newswire
![]() |
- Prestigious Nobel Prize–winning institution confirms adoption of miLab™ following clinical evaluation
- "A milestone signaling broader adoption in advanced global healthcare markets"
YONGIN, South Korea, Oct. 28, 2025 /PRNewswire/ -- Noul Co., Ltd.(CEO David Lim), an AI-driven blood and cancer diagnostics company, announced the supply...
Read more: Noul Supplies AI Diagnostic Platform miLab™ to Charité, Europe's Leading University...















